Xencor (XNCR) Other Non-Current Assets (2013 - 2026)
Xencor's (XNCR) quarterly Other Non-Current Assets came in at $498000.0 in Q1 2026, up 75.35% year-on-year from $284000.0 in Q1 2025, and up 72.32% on a QoQ basis from $289000.0 in Q4 2025.
Xencor (XNCR) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Other Non-Current Assets data on file, last reported at $498000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 75.35% year-over-year to $498000.0 in Q1 2026; TTM through Mar 2026 was $498000.0, a 75.35% increase from a year earlier, with the FY2025 full-year figure at $289000.0, down 41.97% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $498000.0, up from $289000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for XNCR reached as high as $648000.0 in Q4 2023 and fell as low as $284000.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $449285.7 across 5 years, with a median of $449000.0 in 2024.
- Across the five-year window, Other Non-Current Assets sank 98.17% in 2022 and soared 75.35% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $613000.0 in 2022, then increased by 5.71% to $648000.0 in 2023, then declined by 23.15% to $498000.0 in 2024, then plunged by 41.97% to $289000.0 in 2025, then jumped by 72.32% to $498000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $498000.0 in Q1 2026, $289000.0 in Q4 2025, and $288000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 498,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 498,000.00 |
| Dec 31, 2025 | 289,000.00 |
| Sep 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 286,000.00 |
| Mar 31, 2025 | 284,000.00 |
| Dec 31, 2024 | 498,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 498,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 378,000.00 |
| Sep 30, 2022 | 613,000.00 |
| Jun 30, 2022 | 613,000.00 |
| Mar 31, 2022 | 613,000.00 |
| Dec 31, 2021 | 653,000.00 |
| Sep 30, 2021 | 33.46 Mn |
| Jun 30, 2021 | 4.35 Mn |
| Mar 31, 2021 | 10.42 Mn |
| Dec 31, 2020 | 212,000.00 |
| Sep 30, 2020 | 8.61 Mn |